Antimicrobial

Kane Biotech Announces new DispersinB® Publication in Pathogens and Conference PresentationsKane Biotech Announces new DispersinB® Publication in Pathogens and Conference Presentations

Kane Biotech Announces new DispersinB® Publication in Pathogens and Conference Presentations

WINNIPEG, Manitoba, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces the…

8 months ago
Hospitals Switching to New Mattresses From US Med-Equip for Enhanced Patient Safety, ComfortHospitals Switching to New Mattresses From US Med-Equip for Enhanced Patient Safety, Comfort

Hospitals Switching to New Mattresses From US Med-Equip for Enhanced Patient Safety, Comfort

Nuvay™ Pressure-Redistributing Foam Mattresses ​Designed to Help Patients Rest, Heal During Hospital StaysHOUSTON, TX / ACCESSWIRE / August 28, 2024…

8 months ago
Kane Biotech Announces Distribution Agreement with Qatar Datamation Systems for revyve™ Antimicrobial Wound GelKane Biotech Announces Distribution Agreement with Qatar Datamation Systems for revyve™ Antimicrobial Wound Gel

Kane Biotech Announces Distribution Agreement with Qatar Datamation Systems for revyve™ Antimicrobial Wound Gel

Company’s Second Distribution Agreement in Middle EastWINNIPEG, Manitoba, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF)…

8 months ago
Tiffany Goolsby Joins Bitscopic as Pharmacy Subject Matter ExpertTiffany Goolsby Joins Bitscopic as Pharmacy Subject Matter Expert

Tiffany Goolsby Joins Bitscopic as Pharmacy Subject Matter Expert

PALO ALTO, Calif., Aug. 26, 2024 /PRNewswire/ -- Bitscopic, an innovator in healthcare data solutions, is thrilled to announce Tiffany Goolsby…

8 months ago
Kane Biotech Announces Distribution Agreement with Razan Medical Trading for revyve™ Antimicrobial Wound GelKane Biotech Announces Distribution Agreement with Razan Medical Trading for revyve™ Antimicrobial Wound Gel

Kane Biotech Announces Distribution Agreement with Razan Medical Trading for revyve™ Antimicrobial Wound Gel

Company’s First Distribution Agreement in Middle EastWINNIPEG, Manitoba, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF)…

9 months ago
Appili Therapeutics Announces Third Amendment to Arrangement Agreement and Provides Updated on Transaction with AditxtAppili Therapeutics Announces Third Amendment to Arrangement Agreement and Provides Updated on Transaction with Aditxt

Appili Therapeutics Announces Third Amendment to Arrangement Agreement and Provides Updated on Transaction with Aditxt

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, Aug. 21,…

9 months ago
Kane Biotech Receives Funding Support to Expand the revyve™ Antimicrobial Wound Gel FamilyKane Biotech Receives Funding Support to Expand the revyve™ Antimicrobial Wound Gel Family

Kane Biotech Receives Funding Support to Expand the revyve™ Antimicrobial Wound Gel Family

WINNIPEG, Manitoba, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”)…

9 months ago
Cosmos Health Completes Registration Process in Germany to Commence Sales of its C-Scrub Antimicrobial Wash; Enters $750M+ MarketCosmos Health Completes Registration Process in Germany to Commence Sales of its C-Scrub Antimicrobial Wash; Enters $750M+ Market

Cosmos Health Completes Registration Process in Germany to Commence Sales of its C-Scrub Antimicrobial Wash; Enters $750M+ Market

CHICAGO, IL / ACCESSWIRE / August 8, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

9 months ago
Recce Pharmaceuticals Announces Successful Completion of Share Purchase PlanRecce Pharmaceuticals Announces Successful Completion of Share Purchase Plan

Recce Pharmaceuticals Announces Successful Completion of Share Purchase Plan

A$4.4 million of valid applications received for the Share Purchase PlanIn conjunction with recently completed A$8.0 million institutional placement, total…

9 months ago
Cosmos Health Successfully Submits Tender for C-Scrub Wash Chlorhexidine 4% to Supply NHS ScotlandCosmos Health Successfully Submits Tender for C-Scrub Wash Chlorhexidine 4% to Supply NHS Scotland

Cosmos Health Successfully Submits Tender for C-Scrub Wash Chlorhexidine 4% to Supply NHS Scotland

CHICAGO, IL / ACCESSWIRE / July 25, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

10 months ago